Healthcare entity
All 1 tracked stories fall under one category: regulation. ATreat is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 6 average consequence score is above the beat benchmark of 5.2 in the same window.
Last mentioned: Aug 12, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: regulation. ATreat is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 6 average consequence score is above the beat benchmark of 5.2 in the same window. Each story carries 2 original sources on average, compared with 2.2 for the broader beat in this window. CN113693748B appears in 1 tracked Healthcare story from August 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 40 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering CN113693748B. Shared-story counts are live from our verified record — not editorial picks.
Jinan court issues first-instance judgment
The Jinan Intermediate People’s Court finds Angelalign’s MasterForce and ATreat systems infringe Align’s patent, orders cessation of use, and awards RMB 10 million in damages.
Align files ITC complaint
Align Technology files a complaint with the U.S. International Trade Commission seeking to block imports of Angelalign products.
UPC issues preliminary injunction
The Unified Patent Court orders Angelalign to stop infringing Align’s ClinCheck Live Update technology in Europe; later upheld on appeal.
Align files China patent infringement action
Align Technology files suit in the Jinan Intermediate People’s Court asserting patent CN113693748B against Angelalign’s subsidiaries.
A Chinese court ruled Angelalign’s clear-aligner systems infringe Align Technology’s extraction-gap-closure patent, ordering it to cease production and pay RMB 10 million in damages—a milestone for medtech IP enforcement in China.
CN113693748B is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
